CenterWatch
Skip to content
Search Clinical Trials
Clinical Trial Listings
Volunteer
Learn About Clinical Trials
Gaoua, Burkina Faso
Search
Location
Distance
< 2 Miles
search
Actively Recruiting
Disclaimer
Clear Filters
A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis
Phase
3
Span
220 weeks
Sponsor
Eli Lilly and Company
Ina, Nagano
Recruiting
READ MORE
1-1 of 1
keyboard_double_arrow_left
arrow_right_alt
1
arrow_right_alt
keyboard_double_arrow_right